Menu
Menu
We are glad to return to Swiss Biotech Day 2026, where you will have the chance to meet our BioPharma and Medical teams for two days of exciting networking, innovation, and insights sharing on the potential of AI-driven solutions to transform precision medicine.
SOPHiA GENETICS is thrilled to be back at ASCO 2026! Meet our experts at booth #32131 to hear about our biopharma solutions. Learn how we are leveraging our unique AI expertise, to provide an unparalleled offering, unlocking insights from complex data types, driving faster discovery of new stratifying biomarkers, in addition to aiding in the commercialization of precision medicines
We are thrilled to be the inaugural World Companion Diagnostics & Liquid Biopsy Summit Japan. Join us and meet our BioPharma team to learn how we help BioPharma companies address challenges throughout the drug development continuum, enhancing efficiency and precision to accelerate the development of better and more effective precision therapeutics.
SOPHiA GENETICS is thrilled to be back at AACR 2026! Visit us at booth #4248 to learn how we advance data-driven medicine, with our cloud-based SOPHiA DDM™ Platform. Discover how it empowers health data interpretation with advanced analytics modules, simplified reporting, and a global community of healthcare institutions. By harnessing the power of AI and multimodal data-driven analytics, we enable you to advance and streamline global access to precision therapies.
We are thrilled to be back at 16th World Clinical Biomarkers & Companion Diagnostics Summit Europe. Join us and meet our BioPharma team to learn how we help BioPharma companies address challenges throughout the drug development continuum, enhancing efficiency and precision to accelerate the development of better and more effective precision therapeutics.
SOPHiA GENETICS is proud to participate in the 50th National Congress of the Mexican Association of Human Genetics (AMGH) and the 9th Latin American Congress of Human Genetics, organized by AMGH and the Red Latinoamericana de Genética Humana.
📅 November 12–14, 2025
📍 Hotel Sheraton Buganvilias, Puerto Vallarta, Jalisco, Mexico
As a global leader in data-driven medicine, we are thrilled to join this milestone event, bringing together experts, researchers, and clinicians from across Latin America.
📍 Visit us at Booth 6
Our team will be on-site to showcase how the SOPHiA DDM™ Platform transforms complex genomic data into actionable insights—empowering healthcare professionals to accelerate discovery, enhance diagnosis, and drive precision medicine forward.
SOPHiA GENETICS is proud to participate in the Congreso Latinoamericano de Patología 2025, taking place in Santiago, Chile.
📍 Visit us at Booth S5
Our team will be on-site to showcase how SOPHiA GENETICS is transforming pathology and laboratory medicine with data-driven insights. Explore our latest innovations across Liquid Biopsy, Solid Tumors, Hematologic Malignancies, and more—empowering clinicians and researchers to advance precision medicine in Latin America.
We look forward to connecting with the pathology community in Santiago and sharing how our technology is shaping the future of healthcare.
Translating NGS Workflows into Real-World Impact in Hemato-Oncology
You are invited to join our networking event on hematologic malignancies during the 2025 Association of Molecular Pathologists Annual Meeting & Expo in Boston, USA.
Connect with peers and leading experts to explore how NGS-based solutions are advancing the investigation of complex variants in hematological malignancies.
During this event, speakers from renowned institutions will share real-world experiences implementing diverse NGS applications, including:
This is your opportunity to learn how peers are overcoming technical hurdles, realizing practical benefits, and applying NGS strategies to make genomic interpretation and decision-making in blood cancers more efficient.
What: Blood Cancer Showcase at AMP
Where: Omni Hotel - Marquee Room
Date: November 12th
Time: 6:30 pm – 8:15pm
Agenda to follow
Reserve your seat to this exclusive event on Wednesday, November 12th starting at 6:30 pm.
We’re excited to be part of the 36th Brazilian Congress of Medical Genetics, joining experts, researchers, and clinicians from Brazil. Our focus this year is on presenting the most recent launch — SOPHiA DDM™ Enhanced Exome Solutions. Visit us at booth #3 to learn how our technology can empower your work in medical genetics.
SOPHiA GENETICS is thrilled to return and join the genomics community at this year’s American Society of Human Genetics (ASHG) Annual Meeting in Boston, Massachusetts.
Visit Booth #1040 to explore the next-generation SOPHiA DDM™ Platform and Alamut™ Visual Plus, and uncover our latest advancements in Enhanced Exome and Whole Genome Sequencing analytics.
Join us and be part of the conversation with our experts, partners, and users as we tackle the challenges of rare and inherited disorder and pharmacogenomic analysis.
Poster Presentation
Wednesday, Oct 15 | 02:30 – 04:30 PM | Exhibit & Poster Hall, Lower Level Board 8008W
Authored and presented by: Adrian Janiszewski
Co-lab Theater Talk
Thursday, Oct 16 | 12:00 – 12:30 pm | Theatre 1, Exhibit & Poster Hall, Lower Level
Simple workflows for complex genomics: A closer look at our latest enhanced exome and whole genome capabilities
Presented by: Guilherme Yamamoto, Head of Genomics and Bioinformatics Innovation, Dasa Brazil
Presented by: Izabela Matyszczak, Technical Product Management Expert, Genomic Research Expert, SOPHiA GENETICS
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.